Physician profile
Yan Cho
NPI 1306112545
$8,897.21
in general payments reported to CMS, 2019-2025
20 companies · $662 in 2025
The $662 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,068 · 2020: $272 · 2022: $1,343 · 2023: $2,622 · 2024: $1,929 · 2025: $662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,708 · Travel and Lodging: $1,506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,708.22 |
| Travel and Lodging | $1,505.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,452.36 | 2019-2024 | Indigo System, Penumbra System |
| Medtronic, INC. | $1,793.03 | 2022-2024 | In.Pact Admiral, Venaseal, Viance |
| Medtronic Vascular, INC. | $1,136.53 | 2019 | |
| Shockwave Medical, INC | $798.12 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $590.27 | 2019-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Silk Road Medical, INC. | $551.90 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cook Medical LLC | $284.68 | 2019-2023 | Zenith Alpha |
| Novartis Pharmaceuticals Corporation | $271.98 | 2020 | |
| Ethicon US, LLC | $242.02 | 2024-2025 | Surgicel Nu-Knit, Enseal, Echelon; Endopath |
| Lemaitre Vascular, INC. | $175.16 | 2023-2025 | Artegraft Vascular Graft |
| Humacyte Global, INC. | $145.31 | 2025 | Symvess |
| Smith+Nephew, INC. | $121.84 | 2024 | Pico |
| Pacira Pharmaceuticals Incorporated | $121.82 | 2025 | Exparel |
| Merit Medical Systems INC | $55.41 | 2019 | |
| Philips North America LLC | $53.57 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reflow Medical INC | $23.36 | 2025 | |
| Terumo Medical Corporation | $21.94 | 2019 | |
| Janssen Pharmaceuticals, INC | $21.21 | 2019 | |
| Cardiovascular Systems INC. | $20.00 | 2019 | |
| Boston Scientific Corporation | $16.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yan Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.